Intra-operative administration of dexamethasone intravitreal implants (Ozurdex) versus intravitreal Bevacizumab during cataract surgery for improving visual outcomes in the management of diabetic maculopathy in Central Australia.
Phase of Trial: Phase II/III
Latest Information Update: 24 Jun 2016
At a glance
- Drugs Dexamethasone (Primary) ; Bevacizumab
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 12 Mar 2015 New trial record